| Dr Samuel Fam, MD | |
|
650 Joel Dr, Fort Campbell, KY 42223-5318 | |
| (318) 680-6607 | |
| Not Available |
| Full Name | Dr Samuel Fam |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 650 Joel Dr, Fort Campbell, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598875544 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 12430R (Louisiana) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 34678 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel Fam, MD Po Box 31294, Clarksville, TN 37040-0022 Ph: (318) 680-6607 | Dr Samuel Fam, MD 650 Joel Dr, Fort Campbell, KY 42223-5318 Ph: (318) 680-6607 |
News Archive
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
Scientists have discovered a link between a mutated gene and a protein found in dead brain cells of people who suffer from a form of dementia and other neurological disorders.
Entos Pharmaceuticals, a healthcare biotechnology company developing nucleic acid medicines with its Fusogenix drug delivery platform, today announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA vaccine from its prototyping program launched at the onset of the global COVID-19 pandemic.
According to an annual survey released Tuesday by the George Institute for International Health that looks at research and development (R&D) funding of diseases that affect the developing world, the U.S. government in 2008 "remained the single biggest contributor as it again provided almost half of the total funding but the report notes developing countries like Brazil [and] India ... were becoming a growing force," AAP/Sydney Morning Herald reports (Rose, 12/15).
Repros Therapeutics today announced the pricing of its public offering of 690,000 units, consisting of 2,760,000 shares of its common stock, Series A Warrants to purchase 2,070,000 shares of common stock and Series B Warrants to purchase 1,690,500 shares of its common stock, at a price per unit of $17.15.
› Verified 6 days ago
Dr. Balakrishna Mohan Rao, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 650 Joel Dr, Fort Campbell, KY 42223 Phone: 270-798-5931 | |
Dr. John Fernando Chaves, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 650 Joel Dr, Fort Campbell, KY 42223 Phone: 270-798-8400 | |
Dr. Bret W. Logan, M.D, PLC Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Blanchfield Army Community Hospital, 650 Joel Drive, Fort Campbell, KY 42223 Phone: 270-798-8372 Fax: 270-956-0180 | |
Michelle Hornbaker-park, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 650 Joel Dr, Blanchfield Army Community Hospital, Fort Campbell, KY 42223 Phone: 270-798-8106 | |
Dr. Christopher Lee Lange, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 650 Joel Dr, Fort Campbell, KY 42223 Phone: 270-956-0522 | |
Ms. Dominique Starr Crosby Holley, D. O Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 650 Joel Dr, Fort Campbell, KY 42223 Phone: 301-295-4611 |